Table 1.
Classification of CTFR mutations, their impact on the protein.
Mutation class | Class 1 | Class 2 | Class 3 | Class 4 | Class 5 | Class 6 |
---|---|---|---|---|---|---|
Common mutations | G542X | F508del | G551D | R117H | A455E | 4326deITC |
Gly542X | N1303K | G551S | R334W | 2789 + 5G-A | N287Y | |
Frequency (%) | 10% | 70% | 4% | 3% | 3% | |
Disfunction | No stable RNA | CTFR trafficking defects | Defective CTFR regulation | Decreased CFTR conductance | Reduced CTFR synthesis | Decreased CFTR stability |
CFTR protein | ||||||
Membrane location | No | Very low | Present | Present | Reduced | Reduced |
Outcome | No | Poor | Poor | Partly | Good | Good |
Therapeutic proposals | Read-through agents | Correctors+Potentiators | Potentiators | Correctors Potentiators | Stabilizers Amplifiers | Stabilizers Stabilizers |
Licensed drugs | Lumacaftor/ivacaftor F508del | Ivacaftor | Ivacaftor R117H | |||
Clinical conditions | More severe diseases | Less severe diseases |
Clinical features associated with the mutations and corrective therapeutic approaches.